| MeSH term | MeSH ID | Detail |
|---|---|---|
| Uremia | D014511 | 33 associated lipids |
| Kidney Failure, Chronic | D007676 | 51 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Neoplasms, Experimental | D009374 | 10 associated lipids |
| Hypercalcemia | D006934 | 13 associated lipids |
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Autoimmune Diseases | D001327 | 27 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Zhou QL et al. | Polydatin possesses notable anti‑osteoporotic activity via regulation of OPG, RANKL and β‑catenin. | 2016 | Mol Med Rep | pmid:27357904 |
| Lin J et al. | Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus. | 2016 | Nat Commun | pmid:26923114 |
| D'Abramo A et al. | Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. | 2016 | PLoS ONE | pmid:26913505 |
| Lu J et al. | Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. | 2016 | Exp. Biol. Med. (Maywood) | pmid:26908571 |
| Stuss M et al. | Assessment of OPG, RANKL, bone turnover markers serum levels and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. | 2016 | Endokrynol Pol | pmid:26884284 |
| Gluba-Brzózka A et al. | Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. | 2016 | Lipids Health Dis | pmid:26843213 |
| Theodoro LH et al. | Effect of low-level laser therapy as an adjuvant in the treatment of periodontitis induced in rats subjected to 5-fluorouracil chemotherapy. | 2016 | J. Periodont. Res. | pmid:26750739 |
| Mitchell JA et al. | Genetic Risk Scores Implicated in Adult Bone Fragility Associate With Pediatric Bone Density. | 2016 | J. Bone Miner. Res. | pmid:26572781 |
| Melchiorre D et al. | Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A. | 2016 | Haematologica | pmid:26494839 |
| Toffoli B et al. | Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. | 2016 | Mediators Inflamm. | pmid:28070143 |
| Chen H et al. | [Effects of laser solid forming of porous titanium on proliferation of osteoblast and RANKL/OPG expression]. | 2016 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:28070039 |
| Shimazaki E et al. | TGF-β and Physiological Root Resorption of Deciduous Teeth. | 2016 | Int J Mol Sci | pmid:28035998 |
| Bolamperti S et al. | Evidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral Fracture. | 2016 | Biomed Res Int | pmid:27999816 |
| Li Y et al. | Osteoprotegerin polymorphisms are associated with alcohol-induced osteonecrosis of femoral head in Chinese Han population from Henan province. | 2016 | J. Genet. | pmid:27994198 |
| Gómez-Vaquero C et al. | Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis. | 2016 | PLoS ONE | pmid:27911913 |
| Pellegrini GG et al. | Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. | 2016 | Nutrients | pmid:27409635 |
| Nagy EE et al. | High circulating osteoprotegerin levels are associated with non-zero blood groups. | 2016 | BMC Cardiovasc Disord | pmid:27387019 |
| Zhang YY et al. | Osteoprotegerin Promotes Cementoblastic Activity of Murine Cementoblast Cell Line in vitro. | 2016 | Chin J Dent Res | pmid:27379348 |
| Songia P et al. | Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. | 2016 | J. Mol. Cell. Cardiol. | pmid:27338002 |
| Li Y et al. | OPG and RANKL polymorphisms are associated with alcohol-induced osteonecrosis of the femoral head in the north area of China population in men. | 2016 | Medicine (Baltimore) | pmid:27336899 |
| Dolan EB et al. | Thermally induced osteocyte damage initiates pro-osteoclastogenic gene expression in vivo. | 2016 | J R Soc Interface | pmid:27335224 |
| Kassem A et al. | Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. | 2016 | PLoS ONE | pmid:27311019 |
| Wang JH et al. | Dickkopf-1 negatively regulates the expression of osteoprotegerin, a key osteoclastogenesis inhibitor, by sequestering Lrp6 in primary and metastatic lytic bone lesions. | 2016 | Medicine (Baltimore) | pmid:27310953 |
| Sasso GR et al. | Elevated serum osteoprotegerin levels in women: friend or foe? | 2015 Nov-Dec | Rev Assoc Med Bras (1992) | pmid:26841162 |
| Calasans-Maia MD et al. | Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814461 |
| Jianru YI et al. | Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814456 |
| SaÄŸlam M et al. | Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. | 2015 Jan-Feb | J Appl Oral Sci | pmid:25760266 |
| Esteghamati A et al. | Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. | 2015 Aug-Sep | Arch Cardiovasc Dis | pmid:26184866 |
| Verde ME et al. | Effect of Bisphosphonates on the Levels of Rankl and Opg in Gingival Crevicular Fluid of Patients With Periodontal Disease and Post-menopausal Osteoporosis. | 2015 | Acta Odontol Latinoam | pmid:27095621 |
| Li B et al. | Expression of OPG, RANKL, and RUNX2 in rabbit periodontium under orthodontic force. | 2015 | Genet. Mol. Res. | pmid:26782591 |
| Zang L et al. | The effects of lung and prostate cancer bone metastasis on serum osteoprotegerin levels: a meta-analysis. | 2015 | Sci Rep | pmid:26671549 |
| Liu W et al. | Polymorphisms in three genes are associated with hemorrhagic stroke. | 2015 | Brain Behav | pmid:26664786 |
| Widschwendter M et al. | Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers. | 2015 | EBioMedicine | pmid:26629528 |
| Rachner TD and Rauner M | RANKL/OPG in Breast Cancer - Extending Its Territory to BRCA Mutation Carriers. | 2015 | EBioMedicine | pmid:26629502 |
| Niu Y et al. | Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION study. | 2015 | BMC Endocr Disord | pmid:26626139 |
| Pesce Viglietti AI et al. | Brucella abortus Invasion of Osteocytes Modulates Connexin 43 and Integrin Expression and Induces Osteoclastogenesis via Receptor Activator of NF-κB Ligand and Tumor Necrosis Factor Alpha Secretion. | 2015 | Infect. Immun. | pmid:26459511 |
| Nemeth ZK et al. | Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. | 2015 | Sci Rep | pmid:26459001 |
| Zhang HL and Jin X | Relationship between serum adiponectin and osteoprotegerin levels and coronary heart disease severity. | 2015 | Genet. Mol. Res. | pmid:26400332 |
| Ren H et al. | Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line. | 2015 | Mol Med Rep | pmid:26398911 |
| Board-Davies E et al. | Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin. | 2015 | Stem Cells Transl Med | pmid:26378260 |
| Kato G et al. | The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study. | 2015 | Arthritis Res. Ther. | pmid:26373710 |
| Li CW et al. | Opg/Rankl mRNA dynamic expression in the bone tissue of ovariectomized rats with osteoporosis. | 2015 | Genet. Mol. Res. | pmid:26345854 |
| Pan X et al. | Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke. | 2015 | PLoS ONE | pmid:26334877 |
| Wang B et al. | Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone. | 2015 | Sci Rep | pmid:26329493 |
| Ostrowska Z et al. | Selected pro-inflammatory cytokines, bone metabolism, osteoprotegerin, and receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa. | 2015 | Endokrynol Pol | pmid:26323468 |
| Kulcsar-Jakab E et al. | Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study. | 2015 | BMC Musculoskelet Disord | pmid:26311162 |
| Silva Vde O et al. | β-Glucans (Saccharomyces cereviseae) Reduce Glucose Levels and Attenuate Alveolar Bone Loss in Diabetic Rats with Periodontal Disease. | 2015 | PLoS ONE | pmid:26291983 |
| Darabi H et al. | Adiponectin as a Protective Factor Against the Progression Toward Type 2 Diabetes Mellitus in Postmenopausal Women. | 2015 | Medicine (Baltimore) | pmid:26287420 |
| Gennaro G et al. | Green Tea Modulates Cytokine Expression in the Periodontium and Attenuates Alveolar Bone Resorption in Type 1 Diabetic Rats. | 2015 | PLoS ONE | pmid:26270535 |
| Niu Y et al. | Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes. | 2015 | BMC Cardiovasc Disord | pmid:26260869 |
| Miao X et al. | Nanosecond pulsed electric field inhibits proliferation and induces apoptosis in human osteosarcoma. | 2015 | J Orthop Surg Res | pmid:26148858 |
| Fernández-González FJ et al. | Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review. | 2015 | Dental Press J Orthod | pmid:26560822 |
| Bartosińska J et al. | The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland. | 2015 | Mediators Inflamm. | pmid:26146462 |
| Ye XH et al. | Osteoprotegerin polymorphisms in Chinese Han patients with rheumatoid arthritis. | 2015 | Genet. Mol. Res. | pmid:26125863 |
| Yu SG et al. | Ursolic acid derivative ameliorates streptozotocin-induced diabestic bone deleterious effects in mice. | 2015 | Int J Clin Exp Pathol | pmid:26097549 |
| Schmitz F et al. | Repurposing an Osteoporosis Drug for β Cell Regeneration in Diabetic Patients. | 2015 | Cell Metab. | pmid:26094892 |
| Kondegowda NG et al. | Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway. | 2015 | Cell Metab. | pmid:26094891 |
| Telejko B et al. | The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes. | 2015 | Ann Agric Environ Med | pmid:26094529 |
| Ketlogetswe KS et al. | Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men. | 2015 | J. Acquir. Immune Defic. Syndr. | pmid:26090754 |
| Burton LJ et al. | Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. | 2015 | Carcinogenesis | pmid:26069256 |
| Collins FL et al. | Death Receptor 3 (TNFRSF25) Increases Mineral Apposition by Osteoblasts and Region Specific New Bone Formation in the Axial Skeleton of Male DBA/1 Mice. | 2015 | J Immunol Res | pmid:26065008 |
| Zavala-Cerna MG et al. | Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report. | 2015 | J Immunol Res | pmid:26065000 |
| Davenport C et al. | The Effects of Atorvastatin on Arterial Stiffness in Male Patients with Type 2 Diabetes. | 2015 | J Diabetes Res | pmid:26064990 |
| Rzepka R et al. | Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor. | 2015 | BMC Pregnancy Childbirth | pmid:26059227 |
| Weichhaus M et al. | Osteoprotegerin in breast cancer: beyond bone remodeling. | 2015 | Mol. Cancer | pmid:26054853 |
| Kastritis E et al. | Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging. | 2015 | Blood Cancer J | pmid:26047389 |
| Janda K et al. | Cardiovascular risk in chronic kidney disease patients: intima-media thickness predicts the incidence and severity of histologically assessed medial calcification in radial arteries. | 2015 | BMC Nephrol | pmid:26037625 |
| Davenport C et al. | The effects of insulin and liraglutide on osteoprotegerin and vascular calcification in vitro and in patients with type 2 diabetes. | 2015 | Eur. J. Endocrinol. | pmid:26036811 |
| Harrison R et al. | Acute bone response to whole body vibration in healthy pre-pubertal boys. | 2015 | J Musculoskelet Neuronal Interact | pmid:26032203 |
| Duan P et al. | Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. | 2015 | BMC Womens Health | pmid:25884698 |
| Warren JT et al. | Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function. | 2015 | J. Cell. Biochem. | pmid:25864714 |
| Kim KR et al. | 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. | 2015 | PLoS ONE | pmid:25859665 |
| Wu C et al. | Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. | 2015 | Genes Dev. | pmid:25846796 |
| Åšwierkot J et al. | Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis. | 2015 | Arch. Immunol. Ther. Exp. (Warsz.) | pmid:25837853 |
| Hassan SH et al. | Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients. | 2015 | Dis. Markers | pmid:25814780 |
| Folestad A et al. | Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients. | 2015 | Acta Orthop | pmid:25811776 |
| Sutton KM et al. | The functions of the avian receptor activator of NF-κB ligand (RANKL) and its receptors, RANK and osteoprotegerin, are evolutionarily conserved. | 2015 | Dev. Comp. Immunol. | pmid:25796577 |
| Zhao L et al. | Effects of dietary resveratrol on excess-iron-induced bone loss via antioxidative character. | 2015 | J. Nutr. Biochem. | pmid:26239832 |
| Zheng Y et al. | Mesenchymal dental pulp cells attenuate dentin resorption in homeostasis. | 2015 | J. Dent. Res. | pmid:25762594 |
| Tsuruda T | Osteoprotegerin: osteo-vascular connection. | 2015 | J. Atheroscler. Thromb. | pmid:25740050 |
| Shah M et al. | Local origins impart conserved bone type-related differences in human osteoblast behaviour. | 2015 | Eur Cell Mater | pmid:25738584 |
| Alwood JS et al. | Ionizing Radiation Stimulates Expression of Pro-Osteoclastogenic Genes in Marrow and Skeletal Tissue. | 2015 | J. Interferon Cytokine Res. | pmid:25734366 |
| Xiong L et al. | Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption. | 2015 | Proc. Natl. Acad. Sci. U.S.A. | pmid:25733894 |
| Qiao B et al. | Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma. | 2015 | Drug Des Devel Ther | pmid:25733814 |
| Choe CH et al. | Transmembrane protein 173 inhibits RANKL-induced osteoclast differentiation. | 2015 | FEBS Lett. | pmid:25728277 |
| de Molon RS et al. | OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice. | 2015 | J. Bone Miner. Res. | pmid:25727550 |
| Nagy V and Penninger JM | The RANKL-RANK Story. | 2015 | Gerontology | pmid:25720990 |
| Han J et al. | [Determination of bone metabolic marker levels in perio-implant crevicular fluid and analysis of dental implants stability by resonance frequency in the early stage of healing]. | 2015 | Beijing Da Xue Xue Bao | pmid:25686326 |
| Majerczyk M et al. | [Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. | 2015 | Postepy Hig Med Dosw (Online) | pmid:27259222 |
| Fu Y et al. | Involvement of the Ca²⺠signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation. | 2015 | J. Vet. Sci. | pmid:25549213 |
| Lin TH et al. | NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. | 2015 | Tissue Eng Part A | pmid:25518013 |
| Kuroyanagi G et al. | Resveratrol amplifies BMP-4-stimulated osteoprotegerin synthesis via p38 MAP kinase in osteoblasts. | 2015 | Mol Med Rep | pmid:26044505 |
| Kadlub N et al. | The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. | 2015 | J. Bone Miner. Res. | pmid:25491283 |
| Rao M et al. | Osteoclasts are dispensable for hematopoietic progenitor mobilization by granulocyte colony-stimulating factor in mice. | 2015 | Exp. Hematol. | pmid:25461255 |
| Estanislau IM et al. | Pleiotropic effects of statins on the treatment of chronic periodontitis--a systematic review. | 2015 | Br J Clin Pharmacol | pmid:25444240 |
| Lee CJ et al. | Serum osteoprotegerin is associated with arterial stiffness assessed according to the cardio-ankle vascular index in hypertensive patients. | 2015 | J. Atheroscler. Thromb. | pmid:25318352 |
| Meijome TE et al. | GATA-1 deficiency rescues trabecular but not cortical bone in OPG deficient mice. | 2015 | J. Cell. Physiol. | pmid:25205203 |
| Solberg LB et al. | Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes. | 2015 | Histochem. Cell Biol. | pmid:25201349 |
| Maser RE et al. | Osteoprotegerin is a Better Serum Biomarker of Coronary Artery Calcification than Osteocalcin in Type 2 Diabetes. | 2015 | Endocr Pract | pmid:25100392 |
| Potocka-Bakłażec M et al. | Expression of TNF-α, OPG, IL-1β and the presence of the measles virus RNA in the stapes of the patients with otosclerosis. | 2015 | Eur Arch Otorhinolaryngol | pmid:24676726 |